CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

Podobne zapisy

• Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
  od: Ying Yu, i wsp.
  Wydane: (2024-01-01)
• Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia
  od: Wenjie Xiong, i wsp.
  Wydane: (2023-05-01)
• Chronic renal failure with lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia： one case report
  od: Yuan Mei-jie, i wsp.
  Wydane: (2022-10-01)
• CD3xCD20 bispecific antibodies in transformed Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
  od: Morgane Brocard, i wsp.
  Wydane: (2026-03-01)
• Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia)
  od: Maroun Bou Zerdan, i wsp.
  Wydane: (2022-01-01)